Medicon Hellas Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Medicon Hellas.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	19.0%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Medicon Hellas (ATH:MEDIC) Has Announced That It Will Be Increasing Its Dividend To €0.06

Jul 11

Medicon Hellas (ATH:MEDIC) Is Reinvesting At Lower Rates Of Return

Aug 04

There Are Reasons To Feel Uneasy About Medicon Hellas' (ATH:MEDIC) Returns On Capital

Feb 18

Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital

Jun 10

Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)

Apr 30

Investors Could Be Concerned With Medicon Hellas' (ATH:MEDIC) Returns On Capital

Sep 30

Medicon Hellas (ATH:MEDIC) Could Easily Take On More Debt

Jun 07

Based On Its ROE, Is Medicon Hellas S.A. (ATH:MEDIC) A High Quality Stock?

Feb 25

The Returns At Medicon Hellas (ATH:MEDIC) Provide Us With Signs Of What's To Come

Nov 23

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicon Hellas has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ATSE:MEDIC - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	18	1	1	2	N/A
3/31/2024	18	1	0	1	N/A
12/31/2023	19	1	-1	1	N/A
9/30/2023	19	2	0	1	N/A
6/30/2023	20	2	1	2	N/A
3/31/2023	20	2	1	1	N/A
12/31/2022	21	3	1	1	N/A
9/30/2022	21	3	3	3	N/A
6/30/2022	22	3	4	5	N/A
3/31/2022	22	3	4	5	N/A
12/31/2021	22	3	4	5	N/A
9/30/2021	20	3	3	4	N/A
6/30/2021	19	2	2	3	N/A
3/31/2021	17	2	2	3	N/A
12/31/2020	15	1	2	3	N/A
9/30/2020	14	0	2	3	N/A
6/30/2020	13	0	1	2	N/A
3/31/2020	13	0	0	2	N/A
12/31/2019	13	1	0	2	N/A
9/30/2019	14	1	1	2	N/A
6/30/2019	14	0	1	3	N/A
3/31/2019	14	1	2	3	N/A
12/31/2018	14	2	3	3	N/A
9/30/2018	13	3	4	4	N/A
6/30/2018	13	3	5	5	N/A
3/31/2018	13	2	N/A	5	N/A
12/31/2017	13	2	N/A	5	N/A
9/30/2017	13	1	N/A	4	N/A
6/30/2017	13	1	N/A	3	N/A
3/31/2017	13	1	N/A	2	N/A
12/31/2016	13	1	N/A	2	N/A
9/30/2016	13	2	N/A	3	N/A
6/30/2016	12	2	N/A	1	N/A
3/31/2016	12	2	N/A	1	N/A
12/31/2015	11	2	N/A	0	N/A
9/30/2015	11	1	N/A	0	N/A
6/30/2015	11	1	N/A	0	N/A
3/31/2015	11	1	N/A	1	N/A
12/31/2014	11	1	N/A	2	N/A
9/30/2014	11	1	N/A	1	N/A
6/30/2014	11	0	N/A	4	N/A
3/31/2014	11	0	N/A	7	N/A
12/31/2013	11	0	N/A	9	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MEDIC's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if MEDIC's earnings are forecast to grow faster than the Greek market

High Growth Earnings: Insufficient data to determine if MEDIC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MEDIC's revenue is forecast to grow faster than the Greek market.

High Growth Revenue: Insufficient data to determine if MEDIC's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MEDIC's Return on Equity is forecast to be high in 3 years time

Medicon Hellas Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Medicon Hellas S.A. to Report First Half, 2024 Results on Sep 30, 2024

Medicon Hellas (ATH:MEDIC) Has Announced That It Will Be Increasing Its Dividend To €0.06

Dividend of €0.06 announced

New minor risk - Profit margin trend

Medicon Hellas S.A. to Report Q1, 2024 Results on Apr 30, 2024

New minor risk - Financial data availability

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

New major risk - Financial data availability

Medicon Hellas S.A. to Report First Half, 2023 Results on Sep 29, 2023

Investor sentiment improves as stock rises 19%

Medicon Hellas (ATH:MEDIC) Is Reinvesting At Lower Rates Of Return

Upcoming dividend of €0.04 per share at 3.2% yield

Medicon Hellas S.A., Annual General Meeting, Jun 26, 2023

Medicon Hellas S.A., Annual General Meeting, Jun 26, 2023

There Are Reasons To Feel Uneasy About Medicon Hellas' (ATH:MEDIC) Returns On Capital

Investor sentiment improved over the past week

Insufficient new directors

First half 2022 earnings released: EPS: €0.28 (vs €0.34 in 1H 2021)

Medicon Hellas S.A. to Report First Half, 2022 Results on Sep 30, 2022

Investor sentiment improved over the past week

Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital

Medicon Hellas S.A., Annual General Meeting, Jun 27, 2022

Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investors Could Be Concerned With Medicon Hellas' (ATH:MEDIC) Returns On Capital

Medicon Hellas (ATH:MEDIC) Could Easily Take On More Debt

Based On Its ROE, Is Medicon Hellas S.A. (ATH:MEDIC) A High Quality Stock?

New 90-day high: €1.95

New 90-day high: €1.93

New 90-day high: €1.88

The Returns At Medicon Hellas (ATH:MEDIC) Provide Us With Signs Of What's To Come

New 90-day low: €1.64

First half earnings released

First half earnings released

New 90-day low: €1.66

New 90-day low - €1.68

New 90-day low - €1.79

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies